Dr. Joseph P. Balint. Ph.D.
Dr. Balint is a trained immunologist with 25 years of experience in academic and corporate environments. He has taken products from the bench to the bedside, gaining FDA and ISO licensing. Dr. Balint is currently directing Etubics’ laboratory operations where works at the laboratory bench, writes government research grant applications, prepares publications and is in charge of Company intellectual property. He performs animal and human immune assays, serology testing, and cell-line operations. From 1982 to 1989 he was Director of Extracorporeal Products, IMRÉ CORPORATION; from 1989 to 1993 he was head of Product Development and from 1986 to 1996, he was head of the company’s clinical diagnostic laboratory.
Dr. Balint holds a Ph.D. from Rutgers University (Microbiology) and has ASCP certification in Microbiology. He has 10 patents to his name and has published over 45 scientific papers.
Dr. Yvette Latchman, Ph.D.
Director of Immunology
Dr. Latchman is an immunologist and Senior Scientist at Etubics Corporation with research experience in cancer immunotherapy and autoimmunity. She is responsible for carrying out preclinical immunological testing for pipeline product candidates based on the Company’s advanced generation Etubics Platform. Previously, she was a Senior Scientist at TapImmune Inc and an Assistant Member in the Research Department at Bloodworks, an Assistant Professor in the Departments of Hematology and Immunology at the University of Washington. She has contributed to academic and research projects including co-authoring over 35 scientific original articles as well as presenting at multiple conferences over the past decade.
Her postdoctoral training was at Royal Postgraduate Medical School (now Imperial College of Medicine), London, UK and Brigham and Womens’ Hospital, Harvard Medical school, Boston. Dr. Latchman holds a Ph.D from University College in London, UK in Immunology, and an undergraduate degree in Biochemistry from Imperial College in London, UK.
Dr. Adrian Rice, Ph.D.
Vice President, Research
Dr. Rice is an immunologist with an extensive background and practices at Etubics Corporation cellular immunology, antigen processing/presentation, T cell and dendritic cell biology, molecular biology, biochemistry and structural biology. He has been a member of Etubics Corporation research and development team since 2013, where he focuses on developing the Company’s adenoviral Etubics Platform immunotherapy platforms targeting cancers and infectious diseases.
Dr. Rice received his Ph.D. from the California Institute of Technology in Biochemistry and Molecular Biophysics where he was the recipient of the National Science Foundation Graduate Research Fellowship Award. He held a post-doctoral training position in the laboratory of Prof. Michael J. Bevan at the University of Washington Department of Immunology. In addition, he has co-authored 11 scientific publications and presented at and participated in multiple immunotherapy conferences.
Dr. Wei Zhang, Ph.D.
Dr. Zhang is a leader in Ad5 vector construction and pre-clinical evaluation of product candidates. He has over 10 years of research experience in virology, cell biology, immunology, cancer biology, molecular biology and biochemistry and management of multiple research projects. Dr. Zhang focused his research on tumor virus induction mechanisms in the laboratory of Dr. Daniel DiMaio at Yale University. He completed his graduate research with Dr. Shou-jiang Gao while investigating the infection and pathogenesis mechanism of tumor viruses at the University of Texas Health Science Center, San Antonio, TX and the University of Southern California. During his undergraduate and graduate tenure, he has successfully published his research in top-tier journals in the virology and cancer areas. In addition, Dr. Zhang has presented his research at national and international conferences.
Dr. Zhang received his Ph.D. in molecular medicine from the University of Texas Health Science Center, San Antonio in 2012. He received his B.S. in Biological Science from Wuhan University in Wuhan, China in 2006.
Dr. Jessica Sneeden, Ph.D.
Dr. Sneeden performs construction and isolation of Etubics Corporation product candidates. She has over 17 years of combined graduate and professional experience in the design and characterization of proteins with novel properties via protein engineering and development of novel library selection methods. She has an extensive background in protein expression and purification, protein/nucleic acid interactions and enzyme characterization, DNA recombination and repair pathways, with emphasis on DNA polymerases and their interaction with repair factors and DNA. She has previously held positions at the University of Washington, Stratos Genomics, Inc., and the University of California Davis. In addition, she completed her postdoctoral fellowship at the University of Southern California.
Dr. Sneeden holds a Ph.D. in biochemistry from the University of Washington and an undergraduate degree in biochemistry from North Carolina State University. Dr. Sneeden has authored scientific 13 publications and presented her data at multiple conferences.